摘要
新修订《药品管理法》对假药范畴的修改,引发了涉刑药品案件产品定性难题。本文旨在分析涉刑药品案件定性难的原因,并提出措施建议,希望通过法律法规的补充完善与深度解读解决这一问题,进一步实现法律的公平正义。
The newly revised Drug Administration Law has revised the category of counterfeit drugs,causing difficulties in product characterization in criminal drug cases.This paper aims to analyze the reasons behind this issue and to propose clear measures and recommendations.It seeks to address this issue by supplementing and providing a comprehensive interpretation of laws and regulations,ultimately achieving fairness and justice in the legal system.
作者
杨玉颢
刘冬
YANG Yu-hao;LIU Dong(Market Supervision Administration of Dezhou City,Shandong Province;Shandong Medical Products Administration Regional Inspection First Branch)
出处
《中国食品药品监管》
2023年第7期98-103,共6页
China Food & Drug Administration Magazine
关键词
假药
产品定性
非药品
法律适用
counterfeit drugs
product characterization
non-pharmaceuticals
application of law
作者简介
第一作者:杨玉颢,山东省德州市市场监督管理局市场监管综合执法支队副支队长。专业方向:药品监管执法与法律法规研究。
